Thermogenesis Holdings Inc (THMO)

ThermoGenesis Holdings Inc. is a healthcare equipment company focused on technologies for cell banking, cell processing, and cell-based therapeutics. The company develops, commercializes, and markets automated medical device systems used in clinical bio-banking, point-of-care settings, and laboratory cell processing. Its product line includes the AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System for cord blood and therapeutic cell applications, as well as the XP Point-of-Care System and PXP-1000 System for rapid cell processing. ThermoGenesis also offers X-Series products, including X-Lab, X-Wash System, and X-Mini, for general laboratory use. In addition, it provides contract development and manufacturing services for cell and cell-based gene therapies. The company sells its products through independent distributors and direct to end customers in the United States and select international markets, including China, the United Arab Emirates, and Vietnam. Formerly known as Cesca Therapeutics Inc., the company adopted its current name in November 2019 and is headquartered in Rancho Cordova, California.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.